<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05058638</url>
  </required_header>
  <id_info>
    <org_study_id>HUM00156676 Halitosis substudy</org_study_id>
    <nct_id>NCT05058638</nct_id>
  </id_info>
  <brief_title>Effectiveness of Aquamin® in Mitigating Halitosis</brief_title>
  <official_title>Evaluation of Halitosis Using a Multi-Mineral Approach (Aquamin®)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Michigan</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess whether Aquamin®, a multi-mineral natural product from&#xD;
      red marine algae, can help reduce halitosis when taken for 90 days.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a sub-study to the ongoing clinical trial entitled: Aquamin®, a multi-mineral natural&#xD;
      product from red marine algae, as an adjuvant intervention for mild ulcerative colitis and&#xD;
      ulcerative colitis in remission (HUM00156676) NCT# NCT03869905.&#xD;
&#xD;
      However, the Food and Drug Administration (FDA) indicated that no Investigational New Drug&#xD;
      Application (IND) was required.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">December 2021</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">May 2023</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Halitosis Associated Life-quality Test (HALT) questionnaire (modified)</measure>
    <time_frame>90 days (post-intervention)</time_frame>
    <description>Following the intervention, participants will answer questions regarding if their bad breath has improved over the course of the study compared to the starting point. The scores will be from 0 (no issue) - 5 (worst possible issue) for each question.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Healthy</condition>
  <condition>Halitosis</condition>
  <arm_group>
    <arm_group_label>Aquamin®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Aquamin</intervention_name>
    <description>Participants will take a 90-day supply of Aquamin®, 4 capsules per day; 2 to be taken in the morning and 2 in the evening (containing approximately 800 mg calcium/day).</description>
    <arm_group_label>Aquamin®</arm_group_label>
    <other_name>Nutritional</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Must be able to give written informed consent&#xD;
&#xD;
          -  Willing to follow study procedures of no eating, drinking, smoking or using mouth&#xD;
             rinse 60 minutes before study visits&#xD;
&#xD;
          -  Willing to not scrape their tongue with a toothbrush, oral hygiene aid, or other&#xD;
             utensil during the study participation&#xD;
&#xD;
          -  Periodontally stable&#xD;
&#xD;
          -  Self-reported halitosis&#xD;
&#xD;
          -  A negative pregnancy test for pre-menopausal women with intact female reproductive&#xD;
             organs, and subject must agree to use appropriate birth control over the study period.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant or lactating women&#xD;
&#xD;
          -  Participating in any other interventional trials using an investigational drug&#xD;
&#xD;
          -  Diagnosed with any stomach or intestinal bleeding disorders (gastrointestinal bleeding&#xD;
             from gastric or duodenal ulcers, or gastrin secreting tumors) or active gastric /&#xD;
             duodenal ulcers - peptic ulcer disease (in last 3 months) or with severe symptoms of&#xD;
             ulcerative colitis or Crohn's disease&#xD;
&#xD;
          -  Any gastrointestinal or colonic malignancy- Kidney disease, including kidney &quot;stones&quot;&#xD;
             or hypercalcemia&#xD;
&#xD;
          -  Coagulopathy/hereditary hemorrhagic disorders/or receiving therapeutic doses of&#xD;
             Coumadin or heparin&#xD;
&#xD;
          -  Presence of one or more cavitated carious lesions, untreated dental abscesses&#xD;
             (endodontic or periodontal), untreated periodontitis (gum disease), or oral&#xD;
             pathologies that may contribute to oral malodor (e.g., candidiasis, erosive gingival&#xD;
             conditions)&#xD;
&#xD;
          -  Taking any of the following within 30 days (will be eligible after completing 30 days&#xD;
             of wash out period)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James Varani</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Muhammad N Aslam</last_name>
    <role>Study Director</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Janet Kinney</last_name>
    <role>Study Director</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Muhammad Nadeem Aslam</last_name>
    <phone>734-936-1897</phone>
    <email>mnaslam@umich.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Michigan School of Dentistry</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alice Ou</last_name>
      <phone>734-763-3346</phone>
      <email>aliceou@umich.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 16, 2021</study_first_submitted>
  <study_first_submitted_qc>September 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 28, 2021</study_first_posted>
  <last_update_submitted>October 25, 2021</last_update_submitted>
  <last_update_submitted_qc>October 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>James Varani</investigator_full_name>
    <investigator_title>Professor of Pathology</investigator_title>
  </responsible_party>
  <keyword>Aquamin®</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Halitosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

